Clinical trial

Hydroxyurea in Pulmonary Arterial Hypertension

NCT01950585

StatusWITHDRAWN

Study typeINTERVENTIONAL

Start date2013-09-06

PhaseEARLY_PHASE1

Study timeline

Study start (unknown)2013-09-06Date precision: day

Registry last updated2019-12-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Pulmonary Hypertensionunresolved

Interventions

HydroxyureaDRUG · verified · RxNorm: hydroxyurea

Sponsors & collaborators

National Heart, Lung, and Blood Institute (NHLBI)lead sponsor

The Cleveland Cliniccollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01950585 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.